Rank;Global Rank;Institution;Country;Sector
1;139;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
2;143;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
3;227;Philips Research, Eindhoven;NLD;Companies
4;228;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
5;229;Merck KGaA, Germany;DEU;Companies
6;232;VTT Technical Research Centre of Finland;FIN;Companies
6;232;AstraZeneca, United Kingdom;GBR;Companies
8;286;Novo Nordisk A/S;DNK;Companies
9;301;Siemens AG, Germany;DEU;Companies
10;307;Danone Nederland BV;NLD;Companies
11;322;Bayer AG, Germany;DEU;Companies
12;335;Janssen Research & Development, LLC;BEL;Companies
13;349;Boehringer Ingelheim GmbH Germany;DEU;Companies
14;369;GlaxoSmithKline, United Kingdom;GBR;Companies
15;371;Novartis, Switzerland;CHE;Companies
16;397;AstraZeneca, Sweden;SWE;Companies
17;452;UCB Pharma SA, Brussels;BEL;Companies
18;458;GlaxoSmithKline, Belgium;BEL;Companies
19;479;Sanofi, Germany;DEU;Companies
20;520;Pfizer Inc, United Kingdom;GBR;Companies
21;537;IMEC International;BEL;Companies
22;539;BASF, Germany;DEU;Companies
23;546;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
24;583;SINTEF Group;NOR;Companies